Prevention of allogeneic fetal rejection by tryptophan catabolism
about
Kynurenines in CNS disease: regulation by inflammatory cytokinesThe mysterious case of the C. elegans gut granule: death fluorescence, anthranilic acid and the kynurenine pathwayRemarkable role of indoleamine 2,3-dioxygenase and tryptophan metabolites in infectious diseases: potential role in macrophage-mediated inflammatory diseasesStudies on the specificity of the tetrapyrrole substrate for human biliverdin-IXalpha reductase and biliverdin-IXbeta reductase. Structure-activity relationships define models for both active sitesHistone deacetylase inhibition modulates indoleamine 2,3-dioxygenase–dependent DC functions and regulates experimental graft-versus-host disease in miceEating dirtThe physiological action of picolinic Acid in the human brainThe role of L-tryptophan transport in L-tryptophan degradation by indoleamine 2,3-dioxygenase in human placental explantsPlacentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cellsInterferon-gamma does not break, but promotes the immunosuppressive capacity of adult human mesenchymal stem cellsRegulation of prostaglandin synthesis and cell adhesion by a tryptophan catabolizing enzymePregnancy initiation in the rhesus macaque: towards functional manipulation of the maternal-fetal interfaceDynamic diversity of the tryptophan pathway in chlamydiae: reductive evolution and a novel operon for tryptophan recaptureInflammation Models of Depression in Rodents: Relevance to Psychotropic Drug DiscoveryEndotoxin-Induced Tryptophan Degradation along the Kynurenine Pathway: The Role of Indolamine 2,3-Dioxygenase and Aryl Hydrocarbon Receptor-Mediated Immunosuppressive Effects in Endotoxin Tolerance and Cancer and Its Implications for ImmunoparalysisUnderstanding the role of the kynurenine pathway in human breast cancer immunobiologyTargeting the indoleamine 2,3-dioxygenase pathway in cancerIndoleamine 2,3 Dioxygenase as a Potential Therapeutic Target in Huntington's DiseaseTryptophan metabolism, disposition and utilization in pregnancyThe Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and AutoimmunityThe indoleamine 2,3-dioxygenase (IDO) pathway controls allergyImplication of indolamine 2,3 dioxygenase in the tolerance toward fetuses, tumors, and allograftsThe mTOR pathway and integrating immune regulationThe role of IDO in brain tumor immunotherapyMaternal high fat diet consumption during the perinatal period programs offspring behaviorThe aryl hydrocarbon receptor meets immunology: friend or foe? A little of bothImmunomodulatory effects of adipose-derived stem cells: fact or fiction?Metabolic reprogramming and metabolic dependency in T cellsRegulatory cells and transplantation toleranceTo drive or be driven: the path of a mouse model of recurrent pregnancy lossControlling the Immunological Crosstalk during Conception and Pregnancy: HLA-G in ReproductionRegulatory T-cells in pregnancy: historical perspective, state of the art, and burning questionsMyeloid-derived suppressor cells and anti-tumor T cells: a complex relationshipNeoplastic "Black Ops": cancer's subversive tactics in overcoming host defensesNovel immunotherapies for hematologic malignanciesIDO2 in Immunomodulation and Autoimmune DiseaseTrial watch: IDO inhibitors in cancer therapyThe STING pathway and the T cell-inflamed tumor microenvironmentDisturbed tryptophan metabolism in cardiovascular diseaseImmunoregulatory molecules are master regulators of inflammation during the immune response
P2860
Q21129356-3B386CB0-DE54-4CFF-8EFE-42CC7D6DD2B0Q21131240-045F9C8D-7E37-4C91-A3FD-2C45CA471E4DQ21285076-3F490B37-0F20-47A2-837C-F261E829DD0FQ22254350-09417BC4-C032-4437-BE70-B1608C2B01C1Q24288997-BFCCB309-BFC1-4056-A672-A5AEB67E88D0Q24599065-C93034E9-2F96-4C63-837D-6F450ED6C68FQ24634995-1739F3FD-6C06-4EDD-8863-EEBCF212B9A3Q24647311-685DEF8E-2099-4590-BC7D-BF68B2A2E3E6Q24681236-9EF4F44B-5F0E-42A3-911A-9F8BF00834E1Q24681395-DD8ACDA4-6D6A-426F-A543-A0B971D1F809Q24798233-B0FB739F-3C70-4B04-A6A9-4F3B6D9CA514Q24801034-5B04C16D-6F52-42C6-98CC-7C7748E509C7Q24803902-389CAB5D-B46B-403E-A172-D3AF50C1D47BQ26749497-7404D0EA-10FD-4EDA-9575-34AE1CAE874AQ26765777-62522D84-5B63-479C-A1EB-FD80DE3523C6Q26773472-2D4F3D1F-3369-499E-9328-8841E38CD90EQ26775471-26C28855-6CF1-4734-9E45-CB409AE2B371Q26781849-CA635746-6E31-4881-B9F3-4867B1B42B25Q26783616-52C8482F-5066-4E7E-BE3E-EB6C9C0B29A4Q26785900-425C89EC-681F-4B31-823E-C7EC1A3B83ABQ26822976-FE7C77FD-F4AF-47F7-B1F8-AFADBF29F3ABQ26825202-E6DCB03F-9F59-4365-BCD4-998EDF66A59BQ26830354-0633ED41-A851-488A-ABC0-47C17C8AF8B3Q26830399-E8477A66-A404-46ED-8956-335D8C63A55AQ26849202-4E43563F-72A3-4FA8-956D-3525C90F51DCQ26851740-CE74F838-80AC-4031-BC57-EAA199646DC1Q26853443-1DBA2199-CC86-4ADD-A1E2-5B154496440FQ26864319-692A4C50-A2E4-4004-9394-D502EE370D16Q26865816-BC5648B5-D62F-4568-997E-C832CCEFA4D5Q26866038-57A553B6-E587-4F4B-951F-A590DFA32AF5Q26996465-5B3D8CE3-1B96-417E-9CE2-A9CE331DB9C1Q26998637-13A3D357-7BA2-4FF8-8EB6-5BBEF4FA3C90Q27000087-FA0BDF4F-04A2-4E9B-8382-72A4775C9096Q27001081-CA99F941-E296-4409-9C52-0CE34A656EB0Q27004436-6D8C0D25-E218-4C20-83AD-28BC907E0427Q27006786-9B0EC6F4-3DC0-470E-8926-8B1B128FF48FQ27006866-2FCE11CD-B974-4865-8ADB-FF0C845B3800Q27008371-196B52AC-BFF5-495A-85C2-285463EDEC83Q27010486-6C5D99F5-7677-45B0-94BC-7DA9028FD5A6Q27022027-6C05B6F2-E913-4A51-9F81-C450A59A8222
P2860
Prevention of allogeneic fetal rejection by tryptophan catabolism
description
1998 nî lūn-bûn
@nan
1998 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Prevention of allogeneic fetal rejection by tryptophan catabolism
@ast
Prevention of allogeneic fetal rejection by tryptophan catabolism
@en
Prevention of allogeneic fetal rejection by tryptophan catabolism
@en-gb
Prevention of allogeneic fetal rejection by tryptophan catabolism
@nl
type
label
Prevention of allogeneic fetal rejection by tryptophan catabolism
@ast
Prevention of allogeneic fetal rejection by tryptophan catabolism
@en
Prevention of allogeneic fetal rejection by tryptophan catabolism
@en-gb
Prevention of allogeneic fetal rejection by tryptophan catabolism
@nl
prefLabel
Prevention of allogeneic fetal rejection by tryptophan catabolism
@ast
Prevention of allogeneic fetal rejection by tryptophan catabolism
@en
Prevention of allogeneic fetal rejection by tryptophan catabolism
@en-gb
Prevention of allogeneic fetal rejection by tryptophan catabolism
@nl
P2093
P921
P3181
P1433
P1476
Prevention of allogeneic fetal rejection by tryptophan catabolism
@en
P2093
A L Mellor
B Marshall
I Bondarev
J T Attwood
S J Conway
P304
P356
10.1126/SCIENCE.281.5380.1191
P407
P577
1998-08-21T00:00:00Z